Author:
Donato M L,Aleman A,Champlin R E,Saliba R M,Wharton J T,Burke T W,Bodurka D C,Bevers M W,Levenback C F,Wolf J K,Bast R C,Freedman R S,Ippoliti C,Brewer M,Gajewski J L,Gershenson D M
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference25 articles.
1. Oriel KA, Hartenbach EM, Remington PL . Trends in United States ovarian cancer mortality, 1979–1995. Obstet Gynecol 1999; 93: 30–33.
2. Hanai A . Trends and differentials in ovarian cancer: incidence, mortality and survival experience. APMIS 1990; 98 (Suppl. 12): 1–20.
3. Yancik R . Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 1993; 71 (Suppl. 2): 517–523.
4. Gore M, Mainwaring P, A'Hern R et al. Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol 1998; 16: 2426–2434.
5. Donato ML, Gershenson D, Ippoliti C et al. High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant 2000; 25: 1137–1140.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献